Raymond F. Akers Jr., Ph.D., is the Co-Founder and Executive Chairman of Akers Biosciences, Inc. Dr. Akers founded the company in 1989. He has vast experience in the diagnostics industry having co-founded Drug Screening Systems, Inc., a publicly listed company, in 1987, and Akers Medical Technology Inc., in 1984. He was President and Chief Executive Officer of Akers Medical Technology Inc. until 1987, and later Chief Executive Officer and Vice President of Research and Development of Drug Screening Systems, Inc. until the sale of that company in 1989. He holds a Ph.D. in neurochemistry from Northwestern University. Dr. Akers is the inventor of several of the company’s platform technologies including Particle Immuno-Filtration Assay — PIFA — the basis for the company’s flagship rapid test for heparin-induced thrombocytopenia (HIT).